Related Experiment Video
Updated: Aug 10, 2025

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series
Francisca Valenzuela-Molina1,2, Florina I Bura2, Mari C Vázquez-Borrego2
1Surgical Oncology Unit, Department of Surgery, Reina Sofia University Hospital, Cordoba, Spain.
Introduction:
Pseudomyxoma peritonei (PMP) is a rare malignant disease characterized by a massive multifocal accumulation of mucin within the peritoneal cavity. The current treatment option is based on complete cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. However, the recurrence is frequent with subsequent progression and death. To date, most of the studies published in PMP are related to histological and genomic analyses. Thus, the need for further studies unveiling the underlying PMP molecular mechanisms is urgent. In this regard, hypoxia and oxidative stress have been extensively related to tumoral pathologies, although their contribution to PMP has not been elucidated.
Methods:
In this manuscript, we have evaluated, for the first time, the intratumoral real-time oxygen microtension (pO2mt) in the tumor (soft and hard mucin) and surrounding healthy tissue from five PMP patients during surgery. In addition, we measured hypoxia (Hypoxia Inducible Factor-1a; HIF-1α) and oxidative stress (catalase; CAT) markers in soft and hard mucin from the same five PMP patient samples and in five control samples.
Results:
The results showed low intratumoral oxygen levels, which were associated with increased HIF-1α protein levels, suggesting the presence of a hypoxic environment in these tumors. We also found a significant reduction in CAT activity levels in soft and hard mucin compared with healthy tissue samples.
Discussion:
In conclusion, our study provides the first evidence of low intratumoral oxygen levels in PMP patients associated with hypoxia and oxidative stress markers. However, further investigation is required to understand the potential role of oxidative stress in PMP in order to find new therapeutic strategies.
Insights
Pseudomyxoma peritonei (PMP) is linked to low intratumoral oxygen and increased hypoxia markers. This study reveals oxidative stress in PMP, suggesting new therapeutic targets for this rare cancer.
Area of Science:
- Oncology
- Molecular Biology
- Surgical Oncology
Background:
- Pseudomyxoma peritonei (PMP) is a rare malignancy with high recurrence rates after surgery and chemotherapy.
- Current research on PMP primarily focuses on histology and genomics, leaving molecular mechanisms underexplored.
- Hypoxia and oxidative stress are implicated in various cancers but their role in PMP remains unclear.
Purpose of the Study:
- To investigate intratumoral oxygen levels in PMP.
- To assess markers of hypoxia and oxidative stress in PMP tissues.
- To elucidate the contribution of hypoxia and oxidative stress to PMP pathogenesis.
Main Methods:
- Measured real-time intratumoral oxygen microtension (pO2mt) in PMP tumors and surrounding healthy tissue from five patients.
- Quantified Hypoxia Inducible Factor-1α (HIF-1α) and catalase (CAT) activity in PMP tissue samples and controls.
Main Results:
- Demonstrated significantly low intratumoral oxygen levels in PMP.
- Observed increased HIF-1α protein levels, indicating a hypoxic tumor environment.
- Found significantly reduced catalase activity in PMP tissues compared to healthy controls.
Conclusions:
- This study provides the first evidence linking low intratumoral oxygen, hypoxia, and oxidative stress in PMP patients.
- The findings highlight the potential role of hypoxia and oxidative stress in PMP.
- Further research is warranted to explore these mechanisms for novel therapeutic strategies.
More Related Videos
10:46In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment
Published on: March 16, 2018
09:19Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022